ImageneBio (IMA) Capital Expenditures (2020 - 2023)

ImageneBio has disclosed Capital Expenditures across 4 years of filings, most recently posting $262000.0 for Q4 2023.

• Capital Expenditures for Q4 2023 came in at $262000.0, up 127.84% year-over-year; the trailing twelve-month figure through Dec 2023 was $414000.0 (up 59.85% YoY), and the FY2023 annual result was $414000.0, up 59.85% from the prior year.
• Capital Expenditures came in at $262000.0 for Q4 2023 at ImageneBio, up from $152000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $1.7 million in Q4 2021 to a low of -$941000.0 in Q4 2022.
• The 4-year median for Capital Expenditures is $134500.0 (2020), against an average of $228500.0.
• Peak annual rise in Capital Expenditures reached 87000.0% in 2021, while the deepest fall reached 7933.33% in 2021.
• ImageneBio's Capital Expenditures stood at $638000.0 in 2020, then soared by 162.38% to $1.7 million in 2021, then plunged by 156.21% to -$941000.0 in 2022, then jumped by 127.84% to $262000.0 in 2023.
• The last three Capital Expenditures figures came in at $262000.0 (Q4 2023), $152000.0 (Q1 2023), and -$941000.0 (Q4 2022), per Business Quant data.